» Articles » PMID: 35891472

Understanding Immune Responses to Viruses-Do Underlying Th1/Th2 Cell Biases Predict Outcome?

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2022 Jul 27
PMID 35891472
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging and re-emerging viral diseases have increased in number and geographical extent during the last decades. Examples include the current COVID-19 pandemic and the recent epidemics of the Chikungunya, Ebola, and Zika viruses. Immune responses to viruses have been well-characterised within the innate and adaptive immunity pathways with the outcome following viral infection predominantly attributed to properties of the virus and circumstances of the infection. Perhaps the belief that the immune system is often considered as a reactive component of host defence, springing into action when a threat is detected, has contributed to a poorer understanding of the inherent differences in an individual's immune system in the absence of any pathology. In this review, we focus on how these host factors (age, ethnicity, underlying pathologies) may skew the T helper cell response, thereby influencing the outcome following viral infection but also whether we can use these inherent biases to predict patients at risk of a deviant response and apply strategies to avoid or overcome them.

Citing Articles

Delayed viral clearance and altered inflammatory responses affect severity of SARS-CoV-2 infection in aged mice.

Lacasse E, Dubuc I, Gudimard L, Andrade A, Gravel A, Greffard K Immun Ageing. 2025; 22(1):11.

PMID: 40075368 PMC: 11899864. DOI: 10.1186/s12979-025-00503-1.


Exploring Asthma as a Protective Factor in COVID-19 Outcomes.

Quinn A, Zhao L, Bell S, Huq M, Fang Y Int J Mol Sci. 2025; 26(4).

PMID: 40004141 PMC: 11855143. DOI: 10.3390/ijms26041678.


Mucosal Immunization with an Influenza Vector Carrying SARS-CoV-2 N Protein Protects Naïve Mice and Prevents Disease Enhancement in Seropositive Th2-Prone Mice.

Sergeeva M, Vasilev K, Romanovskaya-Romanko E, Yolshin N, Pulkina A, Shamakova D Vaccines (Basel). 2025; 13(1.

PMID: 39852794 PMC: 11769390. DOI: 10.3390/vaccines13010015.


Oral Immunisation With Non-GMO Surface Displayed SARS-CoV-2 Spike Epitopes on Bacteria-Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice.

Vasquez R, Song J, Mendoza R, Hwang I, Bagon B, Engstrand L Microb Biotechnol. 2025; 18(1):e70073.

PMID: 39797809 PMC: 11724470. DOI: 10.1111/1751-7915.70073.


In Asthma, Change Is the Only Constant.

Staples K Am J Respir Crit Care Med. 2024; 211(2):141-142.

PMID: 39700529 PMC: 11812538. DOI: 10.1164/rccm.202411-2290ED.


References
1.
Wang J, Zheng X, Ke X, Dorak M, Shen J, Boodram B . Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol J. 2009; 6:46. PMC: 2679741. DOI: 10.1186/1743-422X-6-46. View

2.
Furuya Y, Roberts S, Hurteau G, Sanfilippo A, Racine R, Metzger D . Asthma increases susceptibility to heterologous but not homologous secondary influenza. J Virol. 2014; 88(16):9166-81. PMC: 4136262. DOI: 10.1128/JVI.00265-14. View

3.
Kunkl M, Frascolla S, Amormino C, Volpe E, Tuosto L . T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis. Cells. 2020; 9(2). PMC: 7072830. DOI: 10.3390/cells9020482. View

4.
Gett A, Hodgkin P . Cell division regulates the T cell cytokine repertoire, revealing a mechanism underlying immune class regulation. Proc Natl Acad Sci U S A. 1998; 95(16):9488-93. PMC: 21365. DOI: 10.1073/pnas.95.16.9488. View

5.
Guenova E, Watanabe R, Teague J, DeSimone J, Jiang Y, Dowlatshahi M . TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res. 2013; 19(14):3755-63. PMC: 3715586. DOI: 10.1158/1078-0432.CCR-12-3488. View